UK Clinical Vaccine Network Virtual Conference 2020

Bringing together and showcasing the work of the UK clinical vaccine community, to facilitate co-operation and collaborate on future challenges.

Register now

Due to ongoing uncertainties surrounding the current pandemic regulations, the faculty of CVNUK decided to replace this year’s physical conference with an online conference which took place on 27th November 2020. This features a variety of presentations focused on the development of a vaccine for Covid-19.

The recordings of the virtual conference are now available.
If you were unable to attend but would still like to view the sessions, please register via the button below and you will receive an email with a link to view the recorded sessions.

If you have any queries please email

See below for the updated timetable.


Prof Mary Slack

Professor Slack is an Independent Consultant Medical Microbiologist. She was formerly employed by Public Health England (PHE) as Consultant Medical Microbiologist and Head of the Haemophilus Reference Unit in the Respiratory & Vaccine Preventable Bacteria Reference Unit, Colindale, London, United Kingdom. She coordinated the laboratory aspects of enhanced population-based surveillance on invasive H. influenzae and pneumococcal disease in England and Wales. From 1975 to 2003 she was the University Lecturer (Honorary Consultant) in Bacteriology at the University of Oxford, being responsible for clinical microbiology teaching to Oxford Clinical Medical Students.

She was formerly Head of the WHO Collaborating Centre for Haemophilus influenzae and Head of the Global Reference Laboratory for H. influenzae in the WHO Global Vaccine-Preventable Invasive Bacterial Disease (VP-IBD) Surveillance Network. She has worked extensively in developing countries- assisting WHO, PATH, IVI, Hib Initiative and PneumoADIP by providing technical support, advice and training for sentinel site surveillance of paediatric bacterial meningitis, pneumonia and sepsis. Her principal research interests include the epidemiology of invasive haemophilus and pneumococcal infections and the impact of Hib and pneumococcal conjugate vaccines. Her findings in these areas have been widely published and presented at national and international meetings.